Chiron Pharmaceuticals Private Limited, a active private limited company, was established on 21 November 2007 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230TN2007PTC065447. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹6.50 M and a paid-up capital of ₹6.50 M.
It upholds a compliant status. Employing 25 professional, Its leadership includes Vijaya Raghavan Vinjamuri (Director), Krishnareddy Gopavarapu (Director), Kannareddy Naveenkumar Reddy (Director). Past directors included Vatturi Venkata Krishna Prasad, Kannareddy Naveenkumar Reddy. It holds ₹4.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.4, 3Rd Street, Ram Nagar North Madipakkam, Chennai, Tamil Nadu, 600091.
U24230TN2007PTC065447
065447
21 November 2007
₹6.50 M
₹6.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Chiron Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijaya Raghavan Vinjamuri | Director | 21 Nov 2007 | Current |
| Krishnareddy Gopavarapu | Director | 23 Sep 2009 | Current |
| Kannareddy Naveenkumar Reddy | Director | 19 Oct 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Sep 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Chiron Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.38% increase. The company also saw a substantial improvement in profitability, with a 100.92% increase in profit. The company's net worth moved up by a moderate rise of 2.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Chiron Pharmaceuticals had a promoter holding of 56.92% and a public holding of 43.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,199,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2018 | Hdfc Bank Limited | ₹4.20 M | Open |
Explore comprehensive loan charge details -
Chiron Pharmaceuticals has a workforce of 25 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Chiron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chiron Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Chiron Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Chiron Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
A charge with Hdfc Bank Limited of Rs. 4.20 M registered on 29 Aug 2018 with Charge ID 100206689 was modified on 22 Sep 2020. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 4.20 M with Charge ID 100206689 was registered on 29 Aug 2018. was documented.
The activity Kannareddy Naveenkumar Reddy was appointed as a Director was appointed as a Director on 19 Oct 2011 & has been associated with this company since 14 years 2 months . was completed.
Krishnareddy Gopavarapu was appointed as a Director was appointed as a Director on 23 Sep 2009 & has been associated with this company since 16 years 2 months . was recorded as a recent event.
The CIN of Chiron Pharmaceuticals Private Limited is U24230TN2007PTC065447.
Chiron Pharmaceuticals Private Limited is headquartered at No.4, 3Rd Street, Ram Nagar North Madipakkam, Chennai, Tamil Nadu, 600091.
Chiron Pharmaceuticals Private Limited was incorporated on 21 November 2007.
The current directors of Chiron Pharmaceuticals Private Limited are
The primary industry of Chiron Pharmaceuticals Private Limited is Trade.
Chiron Pharmaceuticals Private Limited is unlisted.
The authorized capital of Chiron Pharmaceuticals Private Limited is ₹6.50 M, and the paid-up capital is ₹6.50 M.
The compliance status of Chiron Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX